Skip to main content
ABBV logo

AbbVie Inc.

ABBVNYSEHealthcareDrug Manufacturers - General

$286.74Today:- (-)1Y +24.95%

As of Oct 26, 2026 close

Market cap
$507.82B
P/E (TTM)
80.48
Forward P/E
47.79
Dividend yield
2.43%
52-week range
$190.75$291.40
Volume (live)
-
Avg. volume (3M)
4.84M

AbbVie Inc. (ABBV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for AbbVie Inc. stock.

Analyst Consensus Rating

Investment consensus from 31 professional research analysts

Consensus Rating

Buy
Based on 31 unique analysts
(61 total ratings in last 90 days)
Very High Confidence12.0:1 Buy/Sell

Average Price Target

$293.29
+2.28% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ABBV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jason Gerberry
BofA Securities
BuyMaintains
$305.00
Terence Flynn
Morgan Stanley
BuyMaintains
$310.00
Gary Nachman
Canaccord Genuity
BuyReiterates
$290.00
Michael Yee
UBS
HoldMaintains
$275.00
Asad Haider
Goldman Sachs
HoldMaintains
$258.00 → $294.00
Trung Huynh
RBC Capital
BuyMaintains
$280.00
Michael Yee
UBS
HoldMaintains
$275.00
Emily Field
Barclays
BuyMaintains
$300.00 → $325.00
Louise Chen
Scotiabank
BuyMaintains
$320.00
Geoff Meacham
Citi
HoldMaintains
$260.00
David Amsellem
Piper Sandler
BuyReiterates
$303.00
Tracey Ryniec
TopStockAnalysts
SellInitiates Coverage
-
Mohit Bansal
Wells Fargo
BuyMaintains
$300.00
Louise Chen
Scotiabank
BuyMaintains
$320.00
Trung Huynh
RBC Capital
BuyMaintains
$280.00
Sundeep Ganoria
Zacks Equity Research
SellInitiates Coverage
-
Geoff Meacham
Citi
HoldMaintains
$260.00
Evan Seigerman
BMO Capital
BuyMaintains
$300.00
Jason Gerberry
BofA Securities
BuyMaintains
$289.00 → $305.00
Kinjel Shah
Zacks Equity Research
BuyInitiates Coverage
-
Vamil Divan
Guggenheim
BuyReiterates
$288.00
Michael Yee
UBS
HoldMaintains
$260.00 → $275.00
David Amsellem
Piper Sandler
BuyReiterates
$303.00
Carter Gould
Cantor Fitzgerald
BuyReiterates
$285.00 → $290.00
Vamil Divan
Guggenheim
BuyReiterates
$288.00
Chris Schott
JP Morgan
BuyReiterates
$285.00 → $300.00
David Risinger
Leerink Partners
BuyReiterates
-
Terence Flynn
Morgan Stanley
BuyReiterates
$310.00
Kanishka Das
Zacks Equity Research
BuyInitiates Coverage
-
David Risinger
Leerink Partners
BuyReiterates
-
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Kinjel Shah
Zacks Equity Research
HoldInitiates Coverage
-
Louise Chen
Scotiabank
BuyMaintains
$280.00
Geoff Meacham
Citi
HoldMaintains
$260.00
Evan Seigerman
BMO Capital
BuyReiterates
$300.00
Gary Nachman
Canaccord Genuity
BuyReiterates
$290.00
Trung Huynh
RBC Capital
BuyMaintains
$280.00
Derek Lewis
Zacks Equity Research
BuyInitiates Coverage
-
Tim Anderson
BofA Securities
BuyReiterates
$282.00 → $289.00
Steve Scala
TD Cowen
BuyMaintains
$280.00
Gary Nachman
Canaccord Genuity
BuyReiterates
$290.00
Matt Phipps
William Blair
BuyMaintains
-
Luisa Hector
Berenberg Bank
BuyReiterates
$275.00
Rajesh Kumar
HSBC
BuyMaintains
$300.00 → $315.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Urmimala Biswas
Zacks Equity Research
HoldInitiates Coverage
-
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$295.00 → $300.00
Alexandria Hammond
Wolfe Research
BuyDowngrades
$300.00
Emily Field
Barclays
BuyReiterates
$300.00
Gavin Clark-Gartner
Evercore ISI Group
BuyInitiates Coverage
$246.00 → $260.00
Kinjel Shah
Zacks Equity Research
SellInitiates Coverage
-
Luisa Hector
Berenberg Bank
BuyMaintains
$275.00
Hans Engel
Erste
BuyDowngrades
-
Terence Flynn
Morgan Stanley
BuyInitiates Coverage
$278.00 → $296.00
Vamil Divan
Guggenheim
BuyReiterates
$261.00 → $288.00
Gary Nachman
Canaccord Genuity
BuyReiterates
$282.00 → $290.00
Matt Phipps
William Blair
BuyReiterates
-
Trung Huynh
RBC Capital
BuyMaintains
$280.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$265.00 → $285.00
Jason Gerberry
BofA Securities
BuyMaintains
$234.00 → $276.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ABBV?

The analyst consensus rating for ABBV is Buy, based on the latest ratings from 31 analysts over the last 90 days.

What is the average price target for ABBV?

The average 12-month price target for ABBV is $293.29, representing an upside of 2.3% from the Oct 26, 2026 close of $286.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.